date:May 07, 2014
of $26.5 million in the prior year period. On a non-GAAP basis, the net loss was $30.5 million for the first quarter of 2014, compared with net loss of $21.5 million in the prior year quarter.
Manufacturing at Clinton/Galva is progressing as planned and we are pleased to report that we have doubled the number of customers shipped to since our update at the end of February, said Tyler Painter, CFO of Solazyme. We made commercial progress across our consumer products, nutrition, encapsulated lubr